BLOG

Patent analysis and insight

Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.

Here are some of the best legal conferences for patent professionals to attend in 2023.

10 Best Conferences for Your IP Practice in 2023

As we hit the ground running in 2023, you may be looking for ways to connect with your fellow patent professionals, get up to speed on the latest developments in legal tech, and be inspired by new solutions to your daily challenges.

Read More
When it comes to PTAB proceedings, which CPC classes are the most common?

PTAB Trends: Most Common CPCs

When it comes to PTAB proceedings, which CPC classes are the most common?

Read More
When it comes to PTAB proceedings, who are the most experienced experts? And who are the most expensive?

PTAB Trends: The Most Experienced and Expensive Experts at the PTAB

When it comes to PTAB proceedings, who are the most experienced experts? And who are the most expensive?

Read More
Take a look at some of the groundbreaking and interesting products from CES 2023 and how such technologies are faring in patent prosecution at the USPTO.

Highlights From Inside CES 2023

The world’s largest and most influential tech event has now concluded in Las Vegas. After going all-virtual in 2021 and suffering reduced attendance in 2022, the Consumer Electronics Show roared back to its pre-COVID splendor in 2023.

Read More
Juristat is always working to improve access and transparency. In 2022 we made it even easier for patent professionals to visualize key data, stay up to date on filings, and produce error-free work.

New in Juristat: Detailed Figure Annotations, 102 Forward Cite Reports, and Prosecution Health Dashboards

Juristat is always working to improve access and transparency. Recently, we've made it even easier for patent professionals to visualize key data, stay up to date on filings, and produce error-free work.

 

Read More
Juristat’s normalized allowance rate factors in both average examiner allowance rate and the USPTO average allowance rate to provide a more specific metric to guide your patent prosecution strategy.

What Is a Normalized Allowance Rate?

Juristat’s normalized allowance rate factors in both average examiner allowance rate and the USPTO average allowance rate to provide a more specific metric to evaluate your patent prosecution strategy.

Read More
USPTO DOCX Filing

USPTO Going All-In on DOCX Filings

 

The USPTO recently published a final rule announcing that it would encourage the transition to filing in DOCX format by imposing new fees on certain documents submitted in a non-DOCX format. The new rule takes effect on April 3, 2023.*

Read More
2022 was an exciting year for Juristat. We’re excited for 2023, but first, let’s look back at the topics that most interested patent professionals in the past year.

Most-Read Posts of 2022

2022 was an exciting year for Juristat. We launched new products like PTAB Expert Search, expanded our industry-leading analytics with 102 Forward Cite Reports, and improved our cutting-edge workflow automation tools to include Juristat OAR with Detailed Figure Annotations.

Read More
In 2022 there was change at the USPTO, but familiar trends dominated in the legislature and the judiciary. Check out the year's news highlights.

2022 Patent News Year in Review

2022 was a year of change at the USPTO, while familiar trends once again dominated in the legislature and the judiciary. Below are a few of the most important patent developments of the year.

 

Read More
Juristat tracks “end-loading,” or a USPTO examiner’s tendency to complete a higher volume of work at the end of the quarter.

Examiners Who Procrastinate and How To Keep Them From Derailing Your Practice

If you knew your assigned USPTO examiner was going to procrastinate on your application, how would it impact your prosecution strategy?

Read More

Are you ready to transform your patent practice?

Patent prosecution is complex – we know. If you’re ready for simpler workflows and more predictable outcomes, give us a call.